In late February 2026, Phathom Pharmaceuticals reported fourth-quarter and full-year 2025 results revealing a much tinyer net loss of US$21.15…
Read More

In late February 2026, Phathom Pharmaceuticals reported fourth-quarter and full-year 2025 results revealing a much tinyer net loss of US$21.15…
Read More